LumiraDx Investor Presentation Deck
March 2023, 32 slides
  1. LumiraDx
  2. Related Decks
  3. Investor Presentation Decks
transforming community based | LumiraDx
| LumiraDx
financial updates | LumiraDx
today transforming community based | LumiraDx
systems need enhanced access to diagnostic testing | LumiraDx
leadership team | LumiraDx
current solutions have major limitations | LumiraDx
we have developed and commercialized an innovative disruptive solution for testing | LumiraDx
platform simplifies scales down and integrates principles used in lab systems | LumiraDx
our platform allows for multiple sample types and test technologies on common strip architecture | LumiraDx
simple common strip design enables low cost and disruptive market pricing | LumiraDx
high sensitivity at driven by technology | LumiraDx
we have launched a broad menu of tests with lab comparable performance | LumiraDx
highly scalable manufacturing enables global growth strategy | LumiraDx
platform strategy focused on improving and expanding the testing experience | LumiraDx
raise the standard for testing performance speed access and experience | LumiraDx
| LumiraDx
| LumiraDx
unmet need for high sensitivity test with a market | LumiraDx
feasibility of high sensitivity results at | LumiraDx
a molecular program demonstrates feasibility to achieve target sensitivity | LumiraDx
molecular program demonstrates feasibility to develop swab based test | LumiraDx
platform offers the benefits of testing with the accuracy of laboratory testing | LumiraDx
consolidate multiple instruments to a single lab comparable platform | LumiraDx
menu expansion leading to new customer acquisition and higher volume per customer | LumiraDx
innovation and growth in high sensitivity respiratory antigen testing | LumiraDx
covid testing infrastructure being redeployed to strengthen community based care | LumiraDx
community respiratory service patient case study | LumiraDx
develop comprehensive test menus by disease and care setting | LumiraDx
appendix | LumiraDx
point of care testing is being adopted | LumiraDx
| LumiraDx
See More
LumiraDx
Investor Presentation Decks
Diagnostics & Research Decks
Healthcare Decks
Explore Topics
Blood
Plasma
Diabetes
Recent decks by LumiraDx
Investor Presentation
September 2022
See all presentations by LumiraDx (2 decks)
Related decks
Kymera
Investor Presentation
August 2023
Kymera
Investor Presentation
June 2023
Genprex
Investor Presentation
October 2022
Kymera
Investor Presentation
November 2023
Minerva
IPO
October 2021
Aeglea BioTherapeutics
Investor Presentation
August 2020
Nemaura Medical
Investor Presentation
November 2023
Bluejay
Investor Presentation
September 2022
Recent decks by LumiraDx
See all presentations (2 decks)
Investor Presentation
September 2022
Kymera
Investor Presentation
August 2023
Kymera
Investor Presentation
June 2023
Genprex
Investor Presentation
October 2022
Kymera
Investor Presentation
November 2023
Minerva
IPO
October 2021
Aeglea BioTherapeutics
Investor Presentation
August 2020
Nemaura Medical
Investor Presentation
November 2023
Bluejay
Investor Presentation
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io